BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24634503)

  • 1. Response.
    Narod S
    J Natl Cancer Inst; 2014 Apr; 106(4):dju046. PubMed ID: 24634503
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular wanderings through the DNA damage response and risk for ovarian cancer.
    Bookman MA
    J Natl Cancer Inst; 2014 Jan; 106(1):djt350. PubMed ID: 24262438
    [No Abstract]   [Full Text] [Related]  

  • 3. RE: PPM1D mutations in circulating white blood cells and the risk for ovarian cancer.
    Qiu H
    J Natl Cancer Inst; 2014 Apr; 106(4):dju045. PubMed ID: 24634502
    [No Abstract]   [Full Text] [Related]  

  • 4. PPM1D mutations in circulating white blood cells and the risk for ovarian cancer.
    Akbari MR; Lepage P; Rosen B; McLaughlin J; Risch H; Minden M; Narod SA
    J Natl Cancer Inst; 2014 Jan; 106(1):djt323. PubMed ID: 24262437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of PPP2R1B gene alterations in primary ovarian cancers.
    Campbell IG; Manolitsas T
    Oncogene; 1999 Nov; 18(46):6367-9. PubMed ID: 10597236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
    Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
    Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets.
    Hirasawa A; Saito-Ohara F; Inoue J; Aoki D; Susumu N; Yokoyama T; Nozawa S; Inazawa J; Imoto I
    Clin Cancer Res; 2003 Jun; 9(6):1995-2004. PubMed ID: 12796361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do cells recover from inhibition by cyclosporine?
    Batiuk TD; Pazderka F; Halloran PF
    Transplant Proc; 1994 Oct; 26(5):2831-2. PubMed ID: 7940892
    [No Abstract]   [Full Text] [Related]  

  • 9. [Protein phosphatases that control cell cycle].
    Shimanuki M
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(10):1621-4. PubMed ID: 8396789
    [No Abstract]   [Full Text] [Related]  

  • 10. The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation.
    Ali AY; Abedini MR; Tsang BK
    Oncogene; 2012 Apr; 31(17):2175-86. PubMed ID: 21927021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAD-mediated apoptotic pathway is associated with human cancer development.
    Stickles XB; Marchion DC; Bicaku E; Al Sawah E; Abbasi F; Xiong Y; Bou Zgheib N; Boac BM; Orr BC; Judson PL; Berry A; Hakam A; Wenham RM; Apte SM; Berglund AE; Lancaster JM
    Int J Mol Med; 2015 Apr; 35(4):1081-7. PubMed ID: 25653146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Function of Proto-oncogene Product PPM1D and Development of PPM1D Inhibitors for Cancer Chemotherapy].
    Kamada R; Chuman Y; Kozakai Y; Sakaguchi K
    Seikagaku; 2015 Oct; 87(5):531-8. PubMed ID: 26638620
    [No Abstract]   [Full Text] [Related]  

  • 13. Smaller protein, larger therapeutic potential: PPM1D as a new therapeutic target in brainstem glioma.
    Reitman ZJ
    Pharmacogenomics; 2014 Sep; 15(13):1639-41. PubMed ID: 25410889
    [No Abstract]   [Full Text] [Related]  

  • 14. Serine/threonine phosphatases in the DNA damage response and cancer.
    Peng A; Maller JL
    Oncogene; 2010 Nov; 29(45):5977-88. PubMed ID: 20838380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wip-ing out cancer.
    Bernards R
    Nat Genet; 2004 Apr; 36(4):319-20. PubMed ID: 15054481
    [No Abstract]   [Full Text] [Related]  

  • 16. CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
    Manzano RG; Montuenga LM; Dayton M; Dent P; Kinoshita I; Vicent S; Gardner GJ; Nguyen P; Choi YH; Trepel J; Auersperg N; Birrer MJ
    Oncogene; 2002 Jun; 21(28):4435-47. PubMed ID: 12080474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
    Marsh DJ; Dahia PL; Zheng Z; Liaw D; Parsons R; Gorlin RJ; Eng C
    Nat Genet; 1997 Aug; 16(4):333-4. PubMed ID: 9241266
    [No Abstract]   [Full Text] [Related]  

  • 18. PPP family of protein Ser/Thr phosphatases: two distinct branches?
    Andreeva AV; Kutuzov MA
    Mol Biol Evol; 2001 Mar; 18(3):448-52. PubMed ID: 11230548
    [No Abstract]   [Full Text] [Related]  

  • 19. A brief introduction to the protein phosphatase families.
    Mustelin T
    Methods Mol Biol; 2007; 365():9-22. PubMed ID: 17200550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phosphoprotein phosphatases and signal transduction in plant cells].
    Oka A; Aoki M; Aoyama T
    Tanpakushitsu Kakusan Koso; 1997 Apr; 42(5):736-43. PubMed ID: 9095669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.